Integration of Surgery in the Multidisciplinary Care of Head and Neck Cancer: Focus on Oral Cavity, Larynx, and Hypopharynx Cancers - 2021 Annual Meeting is organized by American Society for Radiation Oncology (ASTRO).
Course opens: 03/01/2022
Course expires: 02/28/2025
Overview:
In this course, a multidisciplinary, multi-institutional group of experts will provide brief updates as to the latest techniques, approaches, outcomes, and toxicities of their modality in the treatment of patients with newly diagnosed oral cavity, larynx, and hypopharynx cancers. Our panel will include: (1) an oncologic head and neck surgeon to discuss approaches to surgical resection, neck dissection, and sentinel node biopsy; (2) a reconstructive surgeon to discuss options for functional reconstructions of head and neck resections and expected outcomes and rehabilitation; (3) a head and neck medical oncologist to discuss the role of systemic therapy (chemotherapy/immunotherapy) prior to surgery and as part of adjuvant chemoradiation; and (4) a head and neck radiation oncologist to discuss the indications for adjuvant radiation therapy, doses, targets, and techniques. After updates, there will be open discussion of a common cases, to highlight opportunities for multidisciplinary discussion and potential differences in approach. In addition, there will be discussion of clinical trials applicable to these scenarios (current, future, or waiting for results). Overall, this panel is carefully selected as a group of highly recognized, thoughtful experts with opinions on best management.
Learning Objectives:
Upon completion of this activity, participants should be able to:
Accreditation
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
Available Credit
1.25 Certificate of Attendance
This activity was designated for 1.25 AMA PRA Category 1 Credit™.
1.25 SA-CME
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.
The American Society for Radiation Oncology (ASTRO) designates this for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.25 self-assessment credits.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved